FBInvestor
Stocks / Crispr Therapeutics AG
Institutional Ownership

Crispr Therapeutics AG

CUSIP H17182108NAMEN AKTCRSPQ1 2026

Analyst forecast

Analyst recommendation trends (Buy / Hold / Sell consensus) come from a market-data feed. This activates once the forecast feed is connected and this ticker is covered.

Coming soon